Malignant Ovarian Serous Tumor — Research

Malignant Ovarian Serous Tumor — Research · CancerIndex

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

pubmedComputed3 windows · counts computed by CancerIndex from PubMed E-utilities; the exact query is stored with each count.

Window	Period	Exact query	Computed	Source
All time	… → 2026-09-12	`("Malignant Ovarian Serous Tumor"[tiab] OR "Ovary Serous Adenocarcinoma"[tiab])`	2026-09-12	pubmed
Last 5 years	2021-01-01 → 2026-12-31	`("Malignant Ovarian Serous Tumor"[tiab] OR "Ovary Serous Adenocarcinoma"[tiab]) AND (2021/01/01:2026/12/31[dp])`	2026-09-12	pubmed
Last 12 months	2025-09-12 → 2026-09-12	`("Malignant Ovarian Serous Tumor"[tiab] OR "Ovary Serous Adenocarcinoma"[tiab]) AND (2025/09/12:2026/09/12[dp])`	2026-09-12	pubmed

Data updated 18 days agoSource updated unknownsource: pubmed E-utilities

Literature

Linked publications (11)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 1–11 of 11 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Prognostic impact of programmed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor-infiltrating lymphocytes in ovarian high grade serous carcinoma.
· Oncotarget · 2016 · PMID 26625204 · validated civic_curation pubmed
Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patients.
· J Ovarian Res · 2016 · PMID 27209210 · validated civic_curation pubmed
MILO/ENGOT-ov11: Binimetinib Versus Physician's Choice Chemotherapy in Recurrent or Persistent Low-Grade Serous Carcinomas of the Ovary, Fallopian Tube, or Primary Peritoneum.
· J Clin Oncol · 2020 · PMID 32822286 · validated civic_curation pubmed